Nature, Published online: 01 July 2026; doi:10.1038/s41586-026-10621-5 This Perspective examines the challenges and opportunities of genomic sequencing across multiple clinical applications, including genetic therapies, and calls for the establishment of new, centralized reference standards to improve consistency and accuracy in the field of precision medicine.
The proliferation of genomic sequencing and clinical applications necessitates standardized approaches to ensure data consistency and accuracy across rapidly evolving medical technologies.
Establishing centralized reference standards for medical genomics is crucial for advancing precision medicine, improving treatment outcomes, and fostering innovation in genetic therapies.
The fragmented landscape of genomic data will gradually consolidate under agreed-upon reference standards, professionalizing the field and enabling more reliable therapeutic development.
- · Precision medicine companies
- · Genetic therapy developers
- · Healthcare providers
- · Patients with genetic conditions
- · Fragmented genomic data initiatives
- · Companies with proprietary, non-standardized platforms
Improved data interoperability and reliability in genomic sequencing for clinical use.
Accelerated development and adoption of new genetic therapies due to clearer regulatory pathways and more consistent data outcomes.
Enhanced global collaboration in genomic research and clinical diagnostics, potentially leading to new breakthroughs in disease understanding and treatment.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at Nature — Latest Research